1. Low expression associated with reduced CD8+T cell infiltration and poor prognosis in NSCLC;2. Overexpression inhibits tumor growth, reduces metastasis, and reverses immunosuppressive TIME. This evidence concerns the gene CD8A and non-small cell lung carcinoma.